Affluent Medical

Capital/Financing Update • Jan 10, 2022

Half-year liquidity contract statement for Affluent Medical

Affluent Medical

Public limited company with a capital of € 15 256 824 Registered office: 320, avenue Archimède Les Pléiades III - Bâtiment B 13100 Aix-en-Provence - France

837 722 560 R.C.S. on the Aix-en-Provence Trade and Companies Register

Under the liquidity contract entered into between Affluent Medical and Kepler Cheuvreux, the following resources appeared on the liquidity account on December 31st 2021:

• 65,037 shares
• € 67,128.08
• Number of executions on buy side on semester: 468
• Number of executions on sell side on semester: 152
• Traded volume on buy side on semester: 63,699 shares for € 395,295.67
• Traded volume on sell side on semester: 22,553 shares for € 141,841.87

As a reminder:

• the following resources appeared on the last half year statement on 30 June 2021 on the liquidity account:
• 23,891 shares
• € 220,888.97
• Number of executions on buy side on semester: 130
• Number of executions on sell side on semester: 0
• Traded volume on buy side on semester: 23,891 shares for € 179,111.03
• Traded volume on sell side on semester: 0 shares for €0
• the following resources appeared on the liquidity account when the activity started:
• 0 shares
• € 400,000.00

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

PRESS RELEASE

		Buy Side			Sell Side
	Number of executions	Number of shares	Traded volume in EUR	Number of executions	Number of shares	Traded volume in EUR
Total	468	63,699	395,295.67	152	22,553	141,841.87
01/07/2021	1	225	1,521.00	2	442	3,094.00
02/07/2021	6	939	6,422.76	2	383	2,681.00
05/07/2021	15	2,061	13,726.26	1	300	2,070.00
06/07/2021	9	1,656	11,293.92	-	-	-
07/07/2021	12	844	5,637.92	6	500	3,350.00
08/07/2021	5	500	3,275.00	-	-	-
09/07/2021	7	1,980	13,167.00	3	595	4,165.00
12/07/2021	7	600	4,140.00	-	-	-
13/07/2021	3	210	1,428.00	-	-	-
14/07/2021	2	291	1,978.80	1	1	6.81
15/07/2021	8	1,500	10,020.00	-	-	-
16/07/2021	-	-	-	4	1,500	10,245.00
22/07/2021	6	216	1,499.04	-	-	-
23/07/2021	5	1,185	8,223.90	1	1	6.98
26/07/2021	1	1	6.70	-	-	-
27/07/2021	5	324	2,170.80	1	1	6.79
28/07/2021	2	109	730.30	-	-	-
29/07/2021	1	67	448.90	2	208	1,445.60
30/07/2021	2	154	1,031.80	1	1	6.73
02/08/2021	4	56	375.20	-	-	-
03/08/2021	3	291	1,949.70	1	2	13.72
04/08/2021	1	50	337.50	5	250	1,700.00
05/08/2021	9	966	6,491.52	1	1	6.75
06/08/2021	13	2,000	13,140.00	1	15	98.70
09/08/2021	17	2,485	15,904.00	-	-	-
10/08/2021	2	303	1,893.75	1	1	6.36
11/08/2021	10	523	3,247.83	-	-	-
12/08/2021	1	197	1,221.40	-	-	-
13/08/2021	3	500	3,075.00	-	-	-
16/08/2021	15	3,000	17,970.00	-	-	-
17/08/2021	3	500	3,000.00	-	-	-
18/08/2021	4	568	3,408.00	1	1	6.02
19/08/2021	6	995	5,890.40	-	-	-
20/08/2021	8	1,438	8,484.20	-	-	-
23/08/2021	5	900	5,310.00	-	-	-
24/08/2021	4	1,106	6,359.50	-	-	-
25/08/2021	1	194	1,105.80	-	-	-
27/08/2021	2	905	5,031.80	-	-	-
30/08/2021	2	95	522.50	-	-	-
31/08/2021	-	-	-	1	500	2,850.00

PRESS RELEASE

5,950.00	1,000	5	-	-	-	01/09/2021
5,523.19	919	6	-	-	-	02/09/2021
488.43	81	3	2,925.00	500	2	03/09/2021
-	-	-	111.34	19	1	07/09/2021
-	-	-	3,000.00	500	2	08/09/2021
3,010.00	500	1	1,964.72	328	4	09/09/2021
9,498.40	1,532	6	6.07	1	1	10/09/2021
3,001.60	469	2	63.00	10	1	13/09/2021
6.33	1	1	189.30	30	2	14/09/2021
-	-	-	3,129.76	496	3	15/09/2021
3,200.00	500	1	1,871.10	297	2	16/09/2021
5,939.46	918	9	1,058.40	168	1	17/09/2021
130.00	20	1	2,566.60	410	2	20/09/2021
6.40	1	1	-	-	-	21/09/2021
6.39	1	1	7,178.22	1,134	6	22/09/2021
3,176.34	501	4	6.29	1	1	23/09/2021
6.40	1	1	-	-	-	24/09/2021
3,187.20	498	2	2,741.31	429	4	27/09/2021
409.50	63	2	-	-	-	28/09/2021
6.41	1	1	3,660.80	572	3	29/09/2021
-	-	-	1,030.40	161	3	30/09/2021
6.50	1	1	5,369.60	839	3	01/10/2021
3,243.50	499	5	-	-	-	04/10/2021
407.96	62	1	-	-	-	05/10/2021
-	-	-	6,868.80	1,080	4	06/10/2021
26.00	4	1	-	-	-	07/10/2021
-	-	-	1,098.20	170	4	08/10/2021
-	-	-	4,089.40	635	6	11/10/2021
6.43	1	1	616.32	96	2	12/10/2021
-	-	-	2,568.00	400	1	13/10/2021
-	-	-	527.88	83	1	14/10/2021
-	-	-	5,787.00	900	9	15/10/2021
-	-	-	4,273.16	674	5	18/10/2021
-	-	-	1,583.81	251	2	19/10/2021
2,560.00	400	7	1,974.96	312	4	20/10/2021
-	-	-	4,201.72	668	10	21/10/2021
-	-	-	6.28	1	1	22/10/2021
6.39	1	1	6.39	1	1	26/10/2021
1,262.00	200	3	989.10	157	3	27/10/2021
1,427.20	223	2	-	-	-	28/10/2021
-	-	-	3,385.80	540	6	01/11/2021
-	-	-	206.25	33	2	02/11/2021
6.27	1	1	6,236.23	1,001	6	03/11/2021
187.50	30	1	16,865.08	2,878	10	04/11/2021
-	-	-	4,755.86	802	6	05/11/2021
-	-	-	5,076.69	859	12	08/11/2021

PRESS RELEASE

09/11/2021 6 1,079 6,150.30 - - - 10/11/2021 7 900 5,256.00 - - - 11/11/2021 4 1,225 7,117.25 1 1 5.89 12/11/2021 5 1,000 5,850.00 3 30 177.00 15/11/2021 - - - 8 3,340 21,042.00 16/11/2021 1 1 6.03 3 977 5,979.24 17/11/2021 3 491 3,009.83 3 471 2,901.36 18/11/2021 5 291 1,789.65 6 739 4,574.41 19/11/2021 3 219 1,346.85 - - - 22/11/2021 4 560 3,410.40 - - - 23/11/2021 3 365 2,208.25 - - - 24/11/2021 9 1,075 6,503.75 - - - 26/11/2021 4 587 3,516.13 1 500 3,050.00 29/11/2021 8 1,028 6,075.48 2 500 3,000.00 30/11/2021 3 386 2,238.80 1 1 5.81 01/12/2021 3 318 1,860.30 4 500 2,950.00 02/12/2021 2 682 3,996.52 - - - 06/12/2021 1 218 1,264.40 - - - 07/12/2021 6 379 2,243.68 2 501 3,006.00 08/12/2021 5 923 5,473.39 1 1 5.97 10/12/2021 2 251 1,483.41 1 1 5.92 13/12/2021 4 650 3,815.50 - - - 14/12/2021 1 21 121.80 - - - 15/12/2021 1 1 5.86 1 1 5.86 16/12/2021 3 301 1,775.90 1 1 5.90 17/12/2021 4 861 5,036.85 - - - 20/12/2021 4 500 2,875.00 2 500 2,900.00 21/12/2021 3 177 1,008.90 1 1 5.72 22/12/2021 6 830 4,747.60 - - - 23/12/2021 - - - 1 1 5.75 24/12/2021 1 1 5.65 2 856 4,939.12 27/12/2021 8 580 3,271.20 1 1 5.66 28/12/2021 2 420 2,352.00 - - - 30/12/2021 - - - 1 500 2,825.00 31/12/2021 1 9 49.95 - - -

About Affluent Medical

Affluent Medical is a French player in MedTech, founded by Truffle Capital, with the aim of becoming a global leader in the treatment of heart and vascular diseases, which are the leading cause of death worldwide, and of urinary incontinence, which today affects one in four adults. Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas. The four major technologies developed by the Company are currently in the preclinical and clinical study phase. The first medical device should be marketed in Europe with Kalios. For more information, please visit: www.affluentmedical.com

Contacts:

AFFLUENT MEDICAL Jérôme Geoffroy Chief Financial Officer investor@affluentmedical.com

ACTIFIN, financial press relations Jennifer Jullia +33 (0)6 47 97 54 87 jjullia@actifin.fr

ACTIFIN, financial communication Ghislaine Gasparetto +33 (0)6 21 10 49 24 affluentmedical@actifin.fr

DGM, corporate press relations Thomas Roborel de Climens +33 (0)6 14 50 15 84 thomasdeclimens@dgm-conseil.fr